Brief: Active Biotech Announces Rights Issue Of About SEK 70 Mln
Oct 20 (Reuters) - Active Biotech AB (publ)ACTI.ST: SAID ON FRIDAY RESOLVED TO CARRY OUT SHARE ISSUE OF ABOUT SEK 70.3 MILLION BEFORE DEDUCTION OF ISSUE COSTS RIGHTS ISSUE COMPRISES OF UP TO 1,405,902,488 SHARES SUBSCRIPTION PRICE IS SEK 0.05 PER SHARE THROUGH OVER-ALLOTMENT OPTION CAN RECEIVE ADDITIONAL MAXIMUM OF SEK 10.0 MILLION Source text for Workspace: nMFN4kKc5Z Further company coverage: ACTI.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Active Biotech AB publ
See all newsBrief: Active Biotech Says Japan Grants Patent For Laquinimod Ophthalmic Formulation
Brief: Active Biotech Reports Q2 Operating Profit Of SEK -10.2 Mln
Brief: Active Biotech Expands U.S. Collaboration
Brief: Active Biotech Gets Approval To Resume Enrolment In Hovon 172 MF Study
Brief: Active Biotech Q1 Loss After Tax At SEK 8.4 Million